Common Contracts

1 similar null contracts

Licensing and supply agreement for JUXTAPID
July 4th, 2024
  • Filed
    July 4th, 2024

Aegerion Pharmaceuticals has entered into an exclusive licensing agreement with Recordati Rare Diseases for the commercialization of JUXTAPID (lomitapide) in Japan.

AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!